Skip to main content
. 2016 Jul 20;19(7):445–452. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2016.07.06

7.

注:本图得到版权所有者©2011-2016 Journal of Thoracic Disease复制许可。

累积5年复发率直接手术组(Masaoka-Koga staging Ⅲ期)低于诱导治疗组(Masaoka-Koga stage Ⅰ-Ⅲ):23% vs 58%, P < 0.001。

Five-year CIR of Masaoka-Koga staging Ⅲ patients in the DS group was significantly lower than patients of pathological Masaoka-Koga stage Ⅰ-Ⅲ in the IT group (23% vs 58%, P < 0.001).